secwatch.observer — SEC 8-K summary
======================================

Issuer:     TuHURA Biosciences, Inc./NV (HURA)
CIK:        0001498382
Form:       8-K
Filed at:   2025-12-10T23:59:59+00:00
Accession:  0001193125-25-314302
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TuHURA Biosciences prices $15.6M registered direct offering of stock and warrants in three tranches
--------------------------------------------------------------------------------

- TuHURA prices registered direct offering of 9.46M shares and Series A/B warrants at $1.65/unit; warrants exercisable at $1.95 after six months.
- First closing $8.6M on Dec 10; second $5M by Jan 30, 2026; third $2M by Feb 27, 2026; total gross ~$15.6M.
- Net proceeds for working capital and to repay $3.4M bridge note (3%/mo, due Dec 31, 2025) to Matthew Nachtrab Revocable Trust.
- 30-day lock-up for directors/officers; 30-day halt on equity issuance; 6-month ban on variable rate transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525314302/0001193125-25-314302-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1498382/000119312525314302/d79925d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-314302

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer